Evidence map›Paper›PMID 36661729›Full record

ArticleCurrent oncology (Toronto, Ont.)2023

Novel Approach to Improving Specialist Access in Underserved Populations with Suspicious Oral Lesions.

James Nguyen, Susan Yang, Anastasya Melnikova, Mary Abouakl, Kairong Lin, Thair Takesh, Cherie Wink, Anh Le, Diana Messadi, Kathryn Osann and 1 more

Open access · goldAbstract read
In one paragraph

Article in Current oncology (Toronto, Ont.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

James NguyenBeckman Laser Institute and Medical Clinic, University of California Irvine School of Medicine, Irvine, CA 92612, USA.
Susan YangBeckman Laser Institute and Medical Clinic, University of California Irvine School of Medicine, Irvine, CA 92612, USA.
Anastasya MelnikovaBeckman Laser Institute and Medical Clinic, University of California Irvine School of Medicine, Irvine, CA 92612, USA.
Mary AbouaklBeckman Laser Institute and Medical Clinic, University of California Irvine School of Medicine, Irvine, CA 92612, USA.
Kairong LinBeckman Laser Institute and Medical Clinic, University of California Irvine School of Medicine, Irvine, CA 92612, USA.
Thair TakeshBeckman Laser Institute and Medical Clinic, University of California Irvine School of Medicine, Irvine, CA 92612, USA.
Cherie WinkBeckman Laser Institute and Medical Clinic, University of California Irvine School of Medicine, Irvine, CA 92612, USA.
Anh LeDepartment of Oral and Maxillofacial Surgery/Pharmacology, University of Pennsylvania, Philadelphia, PA 19104, USA.
Diana MessadiUCLA School of Dentistry, University of California Los Angeles, Los Angeles, CA 90095, USA.
Kathryn OsannSchool of Medicine, University of California Irvine, Irvine, CA 92617, USA.
Petra Wilder-SmithBeckman Laser Institute and Medical Clinic, University of California Irvine School of Medicine, Irvine, CA 92612, USA.
University of California, Irvine · USUniversity of California, Los Angeles · USUniversity of Pennsylvania · US

Funding

Univ.of Calif., Irvine Cancer Center Support GrantP30CA062203 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI Melanie Funes · 1994 to 2026
$57.9M
NCI NIH HHS P30 CA062203NIH HHS RO1DE030682NIH HHS UH3EBO22623
6 · The paper itself

Abstract

Late detection and specialist referral result in poor oral cancer outcomes globally. High-risk LRMU populations usually do not have access to oral medicine specialists, a specialty of dentistry, whose expertise includes the identification, treatment, and management of oral cancers. To overcome this access barrier, there is an urgent need for novel, low-cost tele-health approaches to expand specialist access to low-resource, remote and underserved individuals. The goal of this study was to compare the diagnostic accuracy of remote versus in-person specialist visits using a novel, low-cost telehealth platform consisting of a smartphone-based, remote intraoral camera and custom software application. A total of 189 subjects with suspicious oral lesions requiring biopsy (per the standard of care) were recruited and consented. Each subject was examined, and risk factors were recorded twice: once by an on-site specialist, and again by an offsite specialist. A novel, low-cost, smartphone-based intraoral camera paired with a custom software application were utilized to perform synchronous remote video/still imaging and risk factor assessment by the off-site specialist. Biopsies were performed at a later date following specialist recommendations. The study's results indicated that on-site specialist diagnosis showed high sensitivity (94%) and moderate specificity (72%) when compared to histological diagnosis, which did not significantly differ from the accuracy of remote specialist telediagnosis (sensitivity: 95%; specificity: 84%). These preliminary findings suggest that remote specialist visits utilizing a novel, low-cost, smartphone-based telehealth tool may improve specialist access for low-resource, remote and underserved individuals with suspicious oral lesions.

Indexed as

TelemedicineVulnerable PopulationsHumansoral cancerscreeningspecialist accesstelehealthunderserved populations

Identifiers

PMID36661729
PMCPMC9858229
OpenAlexW4315646638

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.